Trial NCT02323126

View at ClinicalTrials.gov 
Org. Study IDs: CEGF816X2201C
Secondary IDs: 2014-003731-20

Last trial update was posted on 2022-02-28

MeSH Interventions

Nazartinib Nivolumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non Small Cell Lung Cancer

Stopping Reasons

Sponsor decision due to low patient recruitment caused by the change in the treatment landscape of NSCLC.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID